Intrinsic Value of S&P & Nasdaq Contact Us

Global Roundtable Corporation GRCU OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Global Roundtable Corporation (GRCU) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 34/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
36/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
25/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
36/100
→ Income
GROWTH
90/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — GRCU

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.54
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-0.01 $20.2K $-95.62K -473.4%
2016 $-0.01 $6.8K $-2.78M -40875.7%
2017 $0.00 $112.96K $51.61K 45.7%
2018 $0.00 $142.52K $66.75K 46.8%
2019 $0.00 $182.83K $63.06K 34.5%
2020 $0.00 $191.67K $10.12K 5.3%
2021 $0.00 $135.86K $-520.75K -383.3%
2022 $0.00 $102.08K $-452.05K -442.8%
2023 $0.00 $2.36M $408.83K 17.4%
2024 $0.00 $1.3M $-243.23K -18.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message